UNSPSC 51332400: Antipsychotic carbamates

Antipsychotic drugs made from derivatives of carbamic acid, H2NC(=O)OH, such as N-substituted and O-substituted carbamic acids.

UNSPSC 51332400 Antipsychotic carbamates, a Class code, shows minimal relevant recent activity in state and local procurement. The three most recent opportunities posted under this code are materially unrelated to antipsychotic carbamates: Seminole County, Florida issued an IFB on June 30, 2026 for naloxone and drug deactivation systems; the Texas Health and Human Services Commission posted an RFI on April 3, 2026 exploring direct-to-manufacturer pharmacy programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products across participating states including Oregon. None of these solicitations target antipsychotic medications or carbamate-class compounds. The opportunities represent naloxone procurement, pharmacy benefit-program restructuring, and broad-spectrum generic pharmaceutical supply, respectively—scopes that fall outside the antipsychotic carbamate taxonomy.

State and local procurement activity under this code does not presently reflect demand for antipsychotic carbamates. The issuing bodies span county health departments, state health agencies, and multistate cooperative purchasing vehicles, but their posted requirements diverge substantially from the code's nominal scope. Until opportunities materially aligned with antipsychotic carbamate procurement appear in state and local notice streams, vendors should treat this code as inactive for current business development purposes.